Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure	Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, communication disorder, developmental disability, learning disability, nervous system disorder, neurodevelopmental disorder, psychiatric disorder	Recruiting	Not applicable	2025-06-24		NCT06423664

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Avera Research Institute	1
IDeA States Pediatric Clinical Trials Network	4
National Institutes of Health (NIH)	667
University of New Mexico	69
University of Vermont	35

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Avera Research Institute	Sioux Falls	United States	7
University of New Mexico Health Sciences Center	Albuquerque	United States	12
University of Vermont Medical Center	Burlington	United States	157